Risk Factors for Trypanosoma Cruzi Infection Reactivation in Chagas' Heart Transplant Recipients: Do they Exist?

Journal of Heart and Lung Transplantation

Volumn 27, Issue 10, 2008, Pages 1186-1187

  Theodoropoulos, Tatiana A D ^a   Bestetti, Reinaldo B ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CARDIAC GRAFT REJECTION; CHAGAS DISEASE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; RISK FACTOR; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; HEART TRANSPLANTATION; HUMANS; RISK FACTORS; TRYPANOSOMA CRUZI;

EID: 52949105073     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.06.015     Document Type: Letter

References (5)

1. Campos S.V., Strabelli T.M.V., Amato-Neto V., et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 27 (2008) 597-602
2. Kobashigawa J., and Meiser B.M. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 80 suppl 2S (2005) S235-S243
3. Bestetti R.B., Souza T.R., Lima M.F., Theodoropoulos T.A.D., Cordeiro J.A., and Burdmann E.A. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas' heart transplant recipients. Transplantation 84 (2007) 441-442
4. Theodoropoulos T., Silva A., and Bestetti R. Risk factors for Trypanosoma cruzi infection reactivation in Chagas' heart transplant recipients. Circulation 117 (2008) 131
5. Diez M., Favaloro L., Bertolloti A., et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow up in heart transplantation. Am J Transplant 7 (2007) 1633-1640